To further investigate the prognostic value of combined COPB2 and YAP1 expression on the clinical outcome of HCC patients, we generated a nomogram, which predicted 3- or 5-year survival rates for HCC patients. The gene discussed is COPB2; the disease is hepatocellular carcinoma.